MedTrace Logo

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease

NCT02060565 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2023-07-20

No results posted yet for this study

Summary

The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.

Conditions

Sponsors & Collaborators

  • Association HGE CHU Bordeaux Sud

    lead OTHER

Principal Investigators

  • Juliette Foucher, MD · Association HGE CHU Bordeaux Sud

  • Faiza Chermak, MD · Association HGE CHU Bordeaux Sud

  • Victor de Lédinghen, MD, PhD · Association HGE CHU Bordeaux Sud

  • Jean-Baptiste Hiriart, MD · Association HGE CHU Bordeaux Sud

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2030-01-31
Completion
2034-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02060565 on ClinicalTrials.gov